UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )

 

Filed by the Registrant [X]

Filed by a Party other than the Registrant [  ]

 

Check the appropriate box: 

[  ] Preliminary Proxy Statement
[  ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[  ] Definitive Proxy Statement
[X] Definitive Additional Materials
[  ] Soliciting Material under §240.14a-12

 

SONNET BIOTHERAPEUTICS HOLDINGS, INC.
(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):
 
[X] No fee required.
[  ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

  (1) Title of each class of securities to which transaction applies:
     
  (2) Aggregate number of securities to which transaction applies:
     
  (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
     
  (4) Proposed maximum aggregate value of transaction:
     
  (5) Total fee paid:
     

 

[  ] Fee paid previously with preliminary materials.
[  ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

  (1) Amount Previously Paid:
     
  (2) Form, Schedule or Registration Statement No.:
     
  (3) Filing Party:
     
  (4) Date Filed:
     

 

 

 

 

 

 

EXPLANATORY NOTE

 

The purpose of this Schedule 14A is to file a letter from Sonnet BioTherapeutics Holdings, Inc. that will be delivered to its stockholders beginning on June 14, 2021 advising them of a change in date of the annual meeting of stockholders.

 

 

 

 

SONNET BIOTHERAPEUTICS HOLDINGS, INC.

100 Overlook Center, Suite 102

Princeton, New Jersey 08540

 

NOTICE OF DATE CHANGE FOR THE
ANNUAL MEETING OF STOCKHOLDERS TO THURSDAY JULY 15, 2021

 

To the Stockholders of Sonnet BioTherapeutics Holdings, Inc.:

 

Sonnet BioTherapeutics Holdings, Inc. (“Sonnet”) has changed the date of its upcoming annual meeting of stockholders (the “Annual Meeting”) called for the purpose of approving certain proposals, including the election of directors and the ratification of the appointment of Sonnet’s independent auditing firm for the fiscal year ended September 30, 2021, from June 24, 2021 to Thursday July 15, 2021 at 9:00 a.m., Eastern Time, to be held virtually via the Internet at https://stctransfer.zoom.us/webinar/register/WN_nRBjkIpOTqSbSyBqXlnDjQ.

 

There is no change to the proposals to be presented to our stockholders for consideration at the Annual Meeting.

 

Our proxy materials including our Proxy Statement for the Annual Meeting, our annual report for the fiscal year ended September 30, 2020 and proxy card are available on the Internet at http://onlineproxyvote.com/SONN.

 

Your continuing interest in Sonnet is very much appreciated.

 

  Sincerely,
   
  /s/ Pankaj Mohan, Ph.D.
  Pankaj Mohan, Ph.D.
  Chief Executive Officer and Chairman of the Board

 

 

 

 

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Sonnet BioTherapeutics Charts.
Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Sonnet BioTherapeutics Charts.